secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001558370-24-006534
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Annovis Bio closes common stock purchase agreement with equity line investor
----------------------------------------------------------------------------

- Closed transactions contemplated by Common Stock Purchase Agreement entered April 25, 2024.
- Equity line investor purchased shares; no specific dollar amount or share count disclosed.
- Loeb & Loeb LLP opinion on securities issuance filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000155837024006534/0001558370-24-006534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000155837024006534/anvs-20240502x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-006534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer